Automated full body tumor segmentation in DOTATATE PET/CT for neuroendocrine cancer patients

被引:2
|
作者
Santilli, Alice [1 ]
Panyam, Prashanth [1 ]
Autz, Arthur [1 ]
Wray, Rick [1 ]
Philip, John [2 ]
Elnajjar, Pierre [1 ]
Swinburne, Nathaniel [1 ]
Mayerhoefer, Marius [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Hlth Informat, York Ave, New York, NY 10065 USA
基金
美国国家卫生研究院;
关键词
Automatic segmentation; nnUnet; Neuroendocrine tumor; PET; DOTATATE; Radiology; Tumor burden;
D O I
10.1007/s11548-023-02968-1
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
PurposeNeuroendocrine tumors (NETs) are a rare form of cancer that can occur anywhere in the body and commonly metastasizes. The large variance in location and aggressiveness of the tumors makes it a difficult cancer to treat. Assessments of the whole-body tumor burden in a patient image allow for better tracking of disease progression and inform better treatment decisions. Currently, radiologists rely on qualitative assessments of this metric since manual segmentation is unfeasible within a typical busy clinical workflow.MethodsWe address these challenges by extending the application of the nnU-net pipeline to produce automatic NET segmentation models. We utilize the ideal imaging type of 68Ga-DOTATATE PET/CT to produce segmentation masks from which to calculate total tumor burden metrics. We provide a human-level baseline for the task and perform ablation experiments of model inputs, architectures, and loss functions.ResultsOur dataset is comprised of 915 PET/CT scans and is divided into a held-out test set (87 cases) and 5 training subsets to perform cross-validation. The proposed models achieve test Dice scores of 0.644, on par with our inter-annotator Dice score on a subset 6 patients of 0.682. If we apply our modified Dice score to the predictions, the test performance reaches a score of 0.80.ConclusionIn this paper, we demonstrate the ability to automatically generate accurate NET segmentation masks given PET images through supervised learning. We publish the model for extended use and to support the treatment planning of this rare cancer.
引用
收藏
页码:2083 / 2090
页数:8
相关论文
共 50 条
  • [21] ACTH-Secreting Renal Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT
    Xu, Si
    Liu, Yang
    Zhou, Jinxin
    Zhang, Yifan
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (04) : 378 - 379
  • [22] Concomitant Pancreatitis and Pancreatic Neuroendocrine Tumor on MRI and 68Ga-DOTATATE PET/CT
    Wang, Jiaqiong
    Kuker, Russ
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (09) : 868 - 872
  • [23] Focal Pancreatitis Mimicking Neuroendocrine Tumor on DOTATATE PET/CT With Radiology-Pathology Correlation
    Daggumati, Lasya
    Ballentine, Samuel J.
    Fraum, Tyler J.
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (12) : 1124 - 1125
  • [24] Intrapancreatic Accessory Spleen Mimicking Neuroendocrine Tumor on 68Ga-DOTATATE PET/CT
    Bhure, Ujwal
    Metzger, Juerg
    Keller, Franziska Aebersold
    Zander, Andrea
    Lago, Marisol Perez
    Herring, Kerstin
    Strobel, Klaus
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (09) : 744 - 745
  • [25] Hepatocellular Carcinoma Mimicking Neuroendocrine Tumor Metastasis on 68Ga-DOTATATE PET/CT
    Ulaner, Gary A.
    Bodei, Lisa
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (04) : 330 - 331
  • [26] 68Ga-DOTATATE PET/CT in the Initial Diagnosis of Patients With Clinical, Imaging, and/or Biochemical Suspicion of a Neuroendocrine Tumor
    Metser, Ur
    Ezzat, Shereen
    Singh, Simron
    Myrehaug, Sten
    Rahimi, Shiva
    Gray, Daryl
    Singnurkar, Amit
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (11) : 933 - 936
  • [27] Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
    Kunz, Wolfgang G.
    Eschbach, Ralf S.
    Stahl, Robert
    Kazmierczak, Philipp M.
    Bartenstein, Peter
    Rominger, Axel
    Auernhammer, Christoph J.
    Spitzweg, Christine
    Ricke, Jens
    Cyran, Clemens C.
    CANCER IMAGING, 2018, 18
  • [28] Identification and characterization of myocardial metastases in neuroendocrine tumor patients using 68Ga-DOTATATE PET-CT
    Wolfgang G. Kunz
    Ralf S. Eschbach
    Robert Stahl
    Philipp M. Kazmierczak
    Peter Bartenstein
    Axel Rominger
    Christoph J. Auernhammer
    Christine Spitzweg
    Jens Ricke
    Clemens C. Cyran
    Cancer Imaging, 18
  • [29] Value of Ga-68 DOTATATE PET/CT in Patients with Suspected Neuroendocrine Tumors
    Soydal, C.
    Ozkan, E.
    Bali, E.
    Kucuk, O. N.
    Kir, M. K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S492 - S492
  • [30] Impact on management of Gallium-68 DOTATATE PET/CT in patients with neuroendocrine tumors
    Assiri, Yasser
    Schadde, Erik
    Schibli, Roger
    Schiesser, Marc
    Aeschbach, Daniela
    Trinckauf, Josephine
    Schaefer, Niklaus
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53